SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-212084
Filing Date
2020-08-06
Accepted
2020-08-06 17:21:56
Documents
12
Period of Report
2020-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d18126d8k.htm   iXBRL 8-K 23609
  Complete submission text file 0001193125-20-212084.txt   145568

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20200805.xsd EX-101.SCH 3080
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20200805_lab.xml EX-101.LAB 18137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20200805_pre.xml EX-101.PRE 11414
5 EXTRACTED XBRL INSTANCE DOCUMENT d18126d8k_htm.xml XML 3417
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 201082848
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences